Yoon-Jae Cho

Publication Details

  • An Animal Model of MYC-Driven Medulloblastoma CANCER CELL Pei, Y., Moore, C. E., Wang, J., Tewari, A. K., Eroshkin, A., Cho, Y., Witt, H., Korshunov, A., Read, T., Sun, J. L., Schmitt, E. M., Miller, C. R., Buckley, A. F., McLendon, R. E., Westbrook, T. F., Northcott, P. A., Taylor, M. D., Pfister, S. M., Febbo, P. G., Wechsler-Reya, R. J. 2012; 21 (2): 155-167

    Abstract:

    Medulloblastoma (MB) is the most common malignant brain tumor in children. Patients whose tumors exhibit overexpression or amplification of the MYC oncogene (c-MYC) usually have an extremely poor prognosis, but there are no animal models of this subtype of the disease. Here, we show that cerebellar stem cells expressing Myc and mutant Trp53 (p53) generate aggressive tumors following orthotopic transplantation. These tumors consist of large, pleiomorphic cells and resemble human MYC-driven MB at a molecular level. Notably, antagonists of PI3K/mTOR signaling, but not Hedgehog signaling, inhibit growth of tumor cells. These findings suggest that cerebellar stem cells can give rise to MYC-driven MB and identify a novel model that can be used to test therapies for this devastating disease.

    View details for DOI 10.1016/j.ccr.2011.12.021

    View details for Web of Science ID 000300476000008

    View details for PubMedID 22340590

Stanford Medicine Resources:

Footer Links: